United States · FDA National Drug Code directory
levocetirizine dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-282_acb3404e-c2a4-f21f-5f5b-f0ceab355395
- Product NDC
- 55111-282
- Form
- TABLET, COATED
- Composition / generic term
- levocetirizine dihydrochloride
- Labeler
- Dr.Reddy's laboratories Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110224
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOTTLE (55111-282-01) · 55111-282-01
- 500 TABLET, COATED in 1 BOTTLE (55111-282-05) · 55111-282-05
- 180 TABLET, COATED in 1 BOTTLE (55111-282-18) · 55111-282-18
- 30 TABLET, COATED in 1 BOTTLE (55111-282-30) · 55111-282-30
- 60 TABLET, COATED in 1 BOTTLE (55111-282-60) · 55111-282-60
- 10 BLISTER PACK in 1 CARTON (55111-282-78) / 10 TABLET, COATED in 1 BLISTER PACK (55111-282-79) · 55111-282-78
- 90 TABLET, COATED in 1 BOTTLE (55111-282-90) · 55111-282-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →